AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

FATAL-NSTI Study (Factors Associated With In-hospital mortALity in NSTI).

Recruitingn/aAges 18 Years - anyAllUniversity of Cagliari
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

Necrotizing soft tissue infections (NSTIs) are rare but potentially life-threatening infections involving the skin and underlying tissues such as fat, fascia, and sometimes muscle. They can progress rapidly and, despite modern antibiotics, surgery, and intensive care, are still associated with high in-hospital mortality. A major challenge in the management of NSTIs is early diagnosis. Initial signs and symptoms are often nonspecific and may resemble less severe soft tissue infections, leading to diagnostic and therapeutic delays. Once identified, treatment requires urgent surgery, broad-spectrum antibiotics, and close monitoring, frequently in an intensive care setting. Even with appropriate treatment, the clinical course of NSTIs is highly variable. Some patients recover, while others develop severe complications such as septic shock or multiple organ failure and may die during hospit

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Age 18 years or older * Hospital admission with a diagnosis of necrotizing soft tissue infection, including: Necrotizing fasciitis, Fournier's gangrene, Necrotizing soft tissue infections involving the neck or trunk. Exclusion Criteria: * Age younger than 18 years * Patients with non-necrotizing skin or soft tissue infections * Patients transferred to another hospital before completion of treatment or outcome assessment * Missing data for the primary outcome (in-hospital mortality)
๐Ÿ’Š

What it tests

  • No Intervention: Observational Cohort
๐Ÿ“

Where

4 sites
Cagliari University Hospital "Duilio Casula".
Cagliari, Italy
Niguarda Hospital, Trauma team.
Milan, Italy
San Gerardo Hospital, Department of Surgery
Monza, Italy
Gemelli Hospital, Rome. Department of Surgery.
Roma, Italy
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy